Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma CellsAlboukadel Kassambara(Inserm), Bernard Klein(Inserm)PLoS ONEApril 30, 201310.1371/journal.pone.0062752Cited by 27SaveCiteExport RISWatch citationsRelated PapersThe role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor|Blood|2009|164